Both in Pharmaceuticals
ARS Pharmaceuticals vs Enanta Pharmaceuticals
Over the past year SPRY returned −62.3% and ENTA returned −2.3%; their daily moves had a correlation of 0.26.
SPRY −62.3% ENTA −2.3%Growth of $1, one year, split-adjusted
| Metric | SPRY | ENTA |
|---|---|---|
| Price | $3.38 | $10.71 |
| Market cap | $336.1M | $311.9M |
| Today | −7.65% | −3.95% |
| 1 month | −18.0% | −16.6% |
| 6 months | −60.5% | −25.4% |
| Year to date | −71.0% | −32.1% |
| 1 year | −62.4% | +0.8% |
| Revenue growth (YoY) | +114.2% | −21.6% |
| Gross margin | 61.8% | 100.0% |
| Net margin | −185.2% | −135.8% |
| P/E (TTM) | — | — |
| Price / sales | 2.9× | 4.8× |
| Net cash | -$27.8M | $189.5M |
| Dividend yield | — | — |
| Volatility (60d) | 71.5% | 45.8% |
| Short % of float | 40.5% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).